RE: US Stocks - Intraday Watchlist and Discussion
I don't normally highlight pharma stocks, but the volume profile on ORMP is very strong so I thought it was worth highlighting it's potential turn after a few weeks of pulling back on lighter volume.
isatrader
Fate does not always let you fix the tuition fee. She delivers the educational wallop and presents her own bill - Reminiscences of a Stock Operator.
Fate does not always let you fix the tuition fee. She delivers the educational wallop and presents her own bill - Reminiscences of a Stock Operator.